HOME
ABOUT
PORTFOLIO
TEAM
NEWS
CONTACT
More
Nutcracker Therapeutics Announces $60 Million Series B Financing
Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase 1/1b Clinical Tria